Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerBilling CodesMicrobiology Culture and Typing ProceduresCPT cpt-87153-nucleic-acid-sequencing-organism-typing
    Ask Trek AI about this page

    CPT 87153: Nucleic Acid Sequencing for Organism Typing

    CPT code 87153 describes a laboratory procedure in which a lab analyst performs nucleic acid sequencing on a previously isolated and identified organism to provide more specific taxonomic categorization (for example, strain or type); this is a molecular sequencing-based organism typing service typically performed in a clinical microbiology or specialized molecular diagnostics laboratory and billed as a laboratory diagnostic procedure.

    For related coverage guidance, see recent payer policy updates: Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatment, HIV/AIDS Pharmacologic Prevention and Treatment, Long-Acting Injectable Antiretroviral Agents for HIV.

    Customize your policy alerts

    Sign up for cpt 87153 policy alerts

    Get alerted when payer policies referencing 87153 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Table of contents

    Progress1 / 7

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical & Coding Specifications

    Clinical Context

    A 54-year-old patient presents to an outpatient infectious disease clinic after a bloodstream infection yielded a bacterial isolate in culture. The isolate has been identified at the genus level by routine methods, and the clinician requests nucleic acid sequencing to determine the organism at the type or strain level to guide epidemiology and targeted therapy. The clinical workflow begins with the laboratory receipt of the previously isolated and identified organism (from culture material). A molecular technologist performs nucleic acid extraction and sequencing (for example, Sanger or next-generation sequencing) targeted to organism-specific genes or whole-genome sequencing. Results are interpreted by the lab analyst, incorporated into the microbiology report, and communicated to the ordering infectious disease physician. Typical sites of service include hospital clinical laboratories, reference laboratories, and academic or public health laboratory facilities.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure
    87070Culture, bacterial; any source except urine, with isolation and presumptive identification of isolatesOften precedes sequencing; provides the isolated organism that is submitted for nucleic acid sequencing
    87077Culture, bacteria; limited identification of isolatesMay be performed prior to sequencing when basic identification is completed before molecular typing
    87471Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique, direct probe technique, or sequencingRepresents organism-specific nucleic acid testing that can be complementary to or followed by sequencing for finer typing
    87798Antimicrobial resistance gene detection, multiple genes, multiplex amplified probe techniqueMay be performed in parallel to sequencing to identify resistance determinants alongside organism typing
    88299Unlisted cytogenetic study or molecular pathology procedureUsed when the specific sequencing method or reporting does not map to an existing code and a comparable unlisted code is required for billing.

    Related Modifiers

    8 rows

    ModifierDescriptionWhen to Use
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    62Modifier 62 indicates that two surgeons function as co‑surgeons, each performing distinct parts of the same primary surgical procedure. It is appended to the primary procedure code (and any…- Use modifier -62 when two surgeons act as co‑surgeons (both primary surgeons) on a single definitive primary procedure, each performing distinct parts of the same surgical procedure (append -62 to…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207RG0100X
    208M00000X
    246YC3301X
    2084N0008X
    207QA0401X
    3336C0003X
    261QC0050X
    207K00000X

    Related ICD-10-CM Codes

    26 rows

    ICD-10-CM CodeDescription
    A17.9Tuberculosis of nervous system, unspecified
    A20.9Plague, unspecified
    A27.9Leptospirosis, unspecified
    A32.7Listerial sepsis
    A41.9Sepsis, unspecified organism
    A49.01Methicillin susceptible Staphylococcus aureus infection, unspecified site
    A49.9Bacterial infection, unspecified
    A54.00Gonococcal infection of lower genitourinary tract, unspecified
    A54.02Gonococcal vulvovaginitis, unspecified
    A56.01Chlamydial cystitis and urethritis

    Showing 1–10 of 26

    Related Payer Policy Updates

    Specialty: Infectious Disease1 / 3

    10 rows

    PolicyPayerEffective Date
    Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) for HIV Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    HIV/AIDS Pharmacologic Prevention and Treatmentpremerabluecrossofwashington2026-10-01
    Long-Acting Injectable Antiretroviral Agents for HIVColorado Rocky Mountain Health Plans2026-10-01
    B-Hemolytic Streptococcus TestingOscar Health2026-10-01
    Human Immunodeficiency Virus (HIV) — Coverage Criteria for Testing and Resistance AssaysOscar Health2026-10-01
    Hepatitis Testing (A, B, C, D) Coverage CriteriaOscar Health2026-10-01
    Lyme Disease Testing Coverage CriteriaOscar Health2026-10-01
    Pathogen Panel TestingOscar Health2026-10-01
    Diagnostic Testing of Common Sexually Transmitted InfectionsOscar Health2026-10-01
    Testing for Vector-Borne InfectionsOscar Health2026-10-01

    Related Codes

    87086-CULTURE-BACTERIAL-QUANTITATIVE-COLONY-COUNT

    CPT 87086: Urine Culture with Quantitative Colony Count

    CPT-87040-BLOOD-CULTURE-ISOLATION-PRESUMPTIVE-IDENTIFICATION

    CPT 87040: Blood Bacterial Culture with Isolation and Presumptive ID

    CPT-87045-AEROBIC-BACTERIAL-STOOL-CULTURE-SALMONELLA-SHIGELLA

    CPT 87045: Aerobic Bacterial Stool Culture for Salmonella/Shigella

    CPT-87046-AEROBIC-BACTERIAL-STOOL-CULTURE-PRESUMPTIVE-ID-NON-SALMONELLA-SHIGELLA

    CPT 87046: Aerobic Bacterial Stool Culture, Presumptive ID (non-Salmonella/Shigella)

    CPT-87070-AEROBIC-CULTURE-ISOLATION-PRESUMPTIVE-IDENTIFICATION

    CPT 87070: Aerobic Culture with Isolation and Presumptive Identification

    CPT-87071-AEROBIC-QUANTITATIVE-BACTERIAL-CULTURE-NON-URINE-BLOOD-STOOL

    CPT 87071: Quantitative Aerobic Bacterial Culture, Non-urine/blood/stool

    CPT-87073-ANAEROBIC-CULTURE-NONBLOOD-NONURINE-NONSTOOL

    CPT 87073: Anaerobic Culture, Non-Urine/Blood/Stool

    CPT-87075-ANAEROBIC-CULTURE-IDENTIFICATION-NON-BLOOD-SPECIMEN

    CPT 87075: Anaerobic Culture and Bacterial Identification (Nonblood)

    CPT-87076-ANAEROBIC-ISOLATE-DEFINITIVE-IDENTIFICATION

    CPT 87076: Anaerobic Isolate Identification to Species Level

    CPT-87077-DEFINITIVE-IDENTIFICATION-AEROBIC-ISOLATE

    CPT 87077: Definitive Identification of Aerobic Isolate

    Showing 1–10 of 30

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.